- Home
- IKT vs RPID Comparison
IKT vs RPID Comparison
Compare IKT & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IKT
- RPID
- Stock Information
- Founded
- IKT 2008
- RPID 2006
- Country
- IKT United States
- RPID United States
- Employees
- IKT N/A
- RPID N/A
- Industry
- IKT Biotechnology: Pharmaceutical Preparations
- RPID Medical Specialities
- Sector
- IKT Health Care
- RPID Health Care
- Exchange
- IKT Nasdaq
- RPID Nasdaq
- Market Cap
- IKT 140.5M
- RPID 138.9M
- IPO Year
- IKT 2020
- RPID 2021
- Fundamental
- Price
- IKT $1.85
- RPID $3.36
- Analyst Decision
- IKT Buy
- RPID Buy
- Analyst Count
- IKT 2
- RPID 1
- Target Price
- IKT $8.00
- RPID $8.00
- AVG Volume (30 Days)
- IKT 526.2K
- RPID 78.6K
- Earning Date
- IKT 08-13-2025
- RPID 08-01-2025
- Dividend Yield
- IKT N/A
- RPID N/A
- EPS Growth
- IKT N/A
- RPID N/A
- EPS
- IKT N/A
- RPID N/A
- Revenue
- IKT N/A
- RPID $29,645,000.00
- Revenue This Year
- IKT N/A
- RPID $18.54
- Revenue Next Year
- IKT N/A
- RPID $20.55
- P/E Ratio
- IKT N/A
- RPID N/A
- Revenue Growth
- IKT N/A
- RPID 28.36
- 52 Week Low
- IKT $1.12
- RPID $0.63
- 52 Week High
- IKT $4.20
- RPID $4.04
- Technical
- Relative Strength Index (RSI)
- IKT 47.71
- RPID 48.28
- Support Level
- IKT $1.80
- RPID $3.45
- Resistance Level
- IKT $2.09
- RPID $3.62
- Average True Range (ATR)
- IKT 0.14
- RPID 0.21
- MACD
- IKT 0.03
- RPID -0.03
- Stochastic Oscillator
- IKT 54.72
- RPID 42.25
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
About RPID Rapid Micro Biosystems Inc.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.